40248-34-8 Usage
Description
6-(TRIFLUOROACETYLAMINO)-1-HEXANOL, also known as N-(Trifluoroacetyl)hexanolamine, is a pale yellow solid with unique chemical properties. It is characterized by its trifluoroacetylamino group attached to a hexanol backbone, which grants it specific reactivity and solubility profiles.
Uses
Used in Biosensors:
6-(TRIFLUOROACETYLAMINO)-1-HEXANOL is used as a component in the development of biosensors with pH-independent redox moieties. Its application in this field is due to its ability to maintain stable redox properties across a range of pH levels, making it a valuable asset for creating reliable and accurate biosensing devices.
Used in Chemical Synthesis:
As a pale yellow solid with distinct chemical properties, 6-(TRIFLUOROACETYLAMINO)-1-HEXANOL can be utilized as an intermediate in the synthesis of various organic compounds. Its trifluoroacetylamino group provides a unique point of reactivity, allowing for the creation of a wide array of products with potential applications in pharmaceuticals, materials science, and other industries.
Used in Pharmaceutical Research:
The unique structure of 6-(TRIFLUOROACETYLAMINO)-1-HEXANOL may also make it a candidate for pharmaceutical research, particularly in the development of new drugs. Its specific functional groups could be exploited to target certain biological pathways or to enhance the properties of existing drug molecules.
Used in Material Science:
The chemical properties of 6-(TRIFLUOROACETYLAMINO)-1-HEXANOL may also find applications in material science, where it could be used to develop new materials with specific properties. For example, its trifluoroacetylamino group could be used to create materials with enhanced solubility, stability, or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 40248-34-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,4 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 40248-34:
(7*4)+(6*0)+(5*2)+(4*4)+(3*8)+(2*3)+(1*4)=88
88 % 10 = 8
So 40248-34-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H14F3NO2/c9-8(10,11)7(14)12-5-3-1-2-4-6-13/h13H,1-6H2,(H,12,14)
40248-34-8Relevant articles and documents
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
-
Paragraph 00735-00736, (2021/11/26)
The present disclosure provides modified oligonucleotides and compositions and methods thereof. In some embodiments, provided technologies comprise modified sugars and/or modified internucleotidic linkages. In some embodiments, the present disclosure provides technologies for preparing modified oligonucleotides. In some embodiments, the present disclosure provides chirally controlled oligonucleotide compositions and methods for their preparation and uses.
Rapid Synthesis of Bicyclic N-Heterocyclic Cores from N-Terminal α,β-Unsaturated Diazoketones
Santiago, Jo?o Victor,Burtoloso, Antonio C. B.
, p. 2822 - 2830 (2018/06/04)
A method for the synthesis of bicyclic N-heterocyclic cores from N-terminal α,β-unsaturated diazoketones has been developed. The transformation involves three sequential steps that include N-deprotection, an intramolecular aza-Michael, and a photochemical Wolff rearrangement as a one-pot protocol. By using this strategy, a series of substituted bicyclic N-heterocycles, particularly, indolizidines and pyrrolizidines, were synthesize in good yields.
NOVEL LIVER-TARGETING AGENTS AND THEIR SYNTHESIS
-
Page/Page column 1; 2, (2011/04/19)
This invention provides novel liver targeting agents and their synthetic methods. A liver targeting agent, with a lysine based nitrilo triacetic acid structure as backbone which acquires multivalency with saccharide groups, to bind with a galactosamine chain or lactose chain is disclosed. In particular, only one amino acid L-lysine is involved to provide trivalency. All carboxyl groups in Nε-benzyloxycarbonyl-Nα-dicarboxymethyl-L-lysine can be conjugated with three glycosides of ahGalNAc or ahLac in one step. This invention also provides a hexa-lactoside. In particular, the TFA-AHA-Asp was used to conjugate 2 moles of NTA(ahLac)3. This invention also provides a method for adding a spacer between NTA and DTPA. The extended hepatocyte-specific glyco-ligand has higher 111In-radiolabelling yield than those non-extended.